NCT04839107

Brief Summary

Creation of an Institutional Registry system for patients with confirmed COVID-19 infection with the collection of epidemiological data, risk factors, diagnosis, prognoses, treatment, follow-up and survival.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 14, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

May 6, 2021

Status Verified

April 1, 2021

Enrollment Period

1.7 years

First QC Date

January 29, 2021

Last Update Submit

May 2, 2021

Conditions

Covid19

Outcome Measures

Primary Outcomes (2)

  • Mortality rate

    Proportion of deceased persons from PCR positivity to epidemiological status out of the total number of infected persons followed in the same period

    From the date of the positivization of the PCR to the date of death or epidemiological discharge, whichever occurs first, assessed up to 30 days.

  • Readmission rate

    Requirements for re-admission during the post-discharge period for a COVID hospitalization

    Within a month of discharge

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients diagnosed with COVID-19, evaluated and followed in the hospital.

You may qualify if:

  • Patient assisted by HIBA adult services
  • Patient diagnosed with COVID-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Italiano

CABA, Buenos Aires F.D., C1199, Argentina

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Veronica A Peuchot, MD

CONTACT

4959 0200veronica.peuchot@hospitalitaliano.org.ar

Diego M Sanchez Thomas, MD

CONTACT

4956 0200diegom.sanchez@hospitalitaliano.org.ar

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
10 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2021

First Posted

April 9, 2021

Study Start

April 14, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

May 6, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations

AR(1)